Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Fresenius Kabi Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (280)
Cancellation by sponsor (141)
Prescription medicine registration (13)
Australian public assessment report (AusPar) (6)
Prescription medicine decision summary (2)

Date

2026 (2)
2025 (22)
2024 (49)
2023 (45)
2022 (28)
2021 (13)
2020 (29)
2019 (57)
2018 (16)
2017 (14)
2016 (18)
2015 (19)
2014 (7)
2013 (25)
2012 (18)
2011 (5)
2010 (5)
2009 (1)
2008 (13)
2007 (12)
2006 (26)
2002 (2)
2001 (2)
1994 (5)
1992 (3)
1991 (6)

Search

Sponsor content

442 result(s) found, displaying 61 to 70

OXALIPLATIN KABI oxaliplatin 100mg / 20mL injection concentrated vial Cancelled under Section 30(1)(c) of the Act

24 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
PACLITAXEL KABI paclitaxel 100 mg/16.7 mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act

24 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
WATER FOR INJECTIONS FREEFLEX 100mL injection bag Cancelled under Section 30(1)(c) of the Act

24 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
GLUCOSE 5% FREEFLEX glucose 2.5g/50mL injection bag Cancelled under Section 30(1)(c) of the Act

24 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
FRESOFOL 1% propofol 1g/100mL injection vial Cancelled under Section 30(1)(c) of the Act

24 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
FRESOFOL 1% propofol 500mg/50mL injection vial Cancelled under Section 30(1)(c) of the Act

24 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
FRESOFOL 1% propofol 200mg/20mL injection ampoule Cancelled under Section 30(1)(c) of the Act

24 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
Fresenius Kabi Australia Pty Ltd - Intravenous fluid container, single use (419916)

25 August 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Fresenius Kabi Australia Pty Ltd - Intravenous fluid container, single use.
KABIVEN G 11% 2400mL injection bag Cancelled under Section 30(1)(c) of the Act

13 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
KABIVEN G 11% 1920mL injection bag Cancelled under Section 30(1)(c) of the Act

13 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd

Pages

First page
Previous page
…
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Page 10
Page 11
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.